US specialist eyes using old drugs to treat more infectionsAugust 2nd, 2012 - 2:15 pm ICT by IANS
Washington, Aug 2 (IANS) The prohibitive cost of placing a single new drug on the shelves, amounting to $1 billion, is prompting scientists to look at existing drugs to treat different infections, and an Indian-origin cancer specialist has taken an initiative towards this.
The technique could cut drug development costs and make new medicine available to patients faster, according to researchers from Georgetown University Medical Center (GUMC), Washington.
Sivanesan Dakshanamurthy, assistant professor of oncology, clinical & experimental drug discovery programme, GUMC, and colleagues explain that drug companies must limit efforts to market new drugs because the process is so expensive, time-consuming and prone to failure, the Journal of Medicinal Chemistry reports.
Scientists long have known that drugs already approved for one disease might be effective for others.
However, existing methods to identify new uses for old drugs lack accuracy and have other disadvantages, according to a GUMC statement.
So, Dakshanamurthy’s team developed a comprehensive new computer method called Train-Match-Fit-Streamline (TMFS) that uses 11 factors to quickly pair likely drugs and diseases.
They reported using TMFS to uncover evidence that Celebrex, the popular prescription medicine for pain and inflammation, has a chemical signature and architecture suggesting that it may work against a difficult-to-treat form of cancer.
Likewise, they found that a medicine for hookworm might be re-purposed to cut off the blood supply that enables many forms of cancer to grow and spread.
“We anticipate that expanding our TMFS method to the more than 27,000 clinically active agents available worldwide across all targets will be most useful in the repositioning of existing drugs for new therapeutic targets,” Dakshanamurthy said.
- Inflammation drug promising in depression - Sep 04, 2012
- Drug for rare childhood cancer may help prevent prostate cancer spread - Apr 30, 2011
- Low-cost pain killer can wipe out resistant TB, say researchers - Sep 13, 2012
- Cardiac drug, digoxin, could lower risk for prostate cancer - Apr 04, 2011
- Widely used arthritis pill shows promise against skin cancer - Dec 03, 2010
- Drug therapy shows promise in treating leading cause of childhood blindness - Feb 17, 2011
- Hope for mouth cancer treatment - Jul 03, 2012
- TB-drugome may pave way for anti-TB drug discovery - Nov 09, 2010
- Shark liver compound could treat dengue, hepatitis - Sep 20, 2011
- Sun-triggered protein 'makes skin cancer worse' - Feb 04, 2011
- Drugs checkmating cancer may combat resistant bugs - Dec 23, 2011
- Breast cancer survivors are at higher risk for hip fractures - Feb 03, 2011
- Injectable gel offers hope for arthritis sufferers - Apr 14, 2011
- Bile pigment could stave off cancer, heart disease - Jun 26, 2012
- Arsenic-based agent shuts down hard-to-treat cancers - Dec 23, 2010
Tags: aug 2, blood supply, cancer specialist, celebrex, chemical signature, computer method, drug discovery, experimental drug, georgetown university medical, gumc, hookworm, indian origin, journal of medicinal chemistry, new computer, new drugs, new medicine, prescription medicine, repositioning, therapeutic targets, university medical center